Dementia Clinical Trials
Dementia clinical trials study new therapies, devices, and diagnostic tools for dementia and related neurological symptoms. Corterve gathers actively recruiting Dementia studies from ClinicalTrials.gov so you can filter them by where you live and whether you may qualify. Neurology trials often include cognitive, imaging, or biomarker assessments. This page is informational only and is not medical advice; discuss participation with your neurologist or physician.
Recruiting Dementia studies
- Transcranial Pulse Stimulation of the BrainNCT05910619NAUniversity of FloridaMild DementiaGainesville, Florida
- Evaluating the Effectiveness of the Health App Recommendation ToolNCT07216716NAUniversity of PittsburghAlzheimers Disease Related DementiasPittsburgh, Pennsylvania
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)NCT04363684Mayo ClinicFrontotemporal Lobar Degeneration (FTLD)Birmingham, Alabama
- Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partnersNCT07018726NAMassachusetts General HospitalYoung Onset DementiaBoston, Massachusetts
- Enhancing Shared Decision-making to Guide Care for People With Dementia and DiabetesNCT05643144NAIndiana UniversityDiabetesIndianapolis, Indiana
- The Volunteering-in-Place Program for Apathetic Assisted Living Residents With ADRDNCT06735950NAUniversity of Maryland, BaltimoreApathy in DementiaCatonsville, Maryland
- Genetic Characterization of Movement Disorders and DementiasNCT02014246National Institute on Aging (NIA)DementiaBaltimore, Maryland
- NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASENCT07667478NAChi-Ying (Roy) LinAlzheimer s DiseaseHouston, Texas
- Visual Hallucinations in Lewy Body DiseasesNCT07849413NYU Langone HealthLewy Body DiseaseNew York, New York
- Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia PsychosisNCT07029581PHASE2ACADIA Pharmaceuticals Inc.Lewy Body Dementia PsychosisIrvine, California
- Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia PsychosisNCT07095465PHASE3ACADIA Pharmaceuticals Inc.Lewy Body Dementia PsychosisIrvine, California
- A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaNCT06651567PHASE2Intra-Cellular Therapies, Inc.Agitation Associated With Alzheimer's DementiaAnaheim, California
Dementia trials by state
Dementia trials by metro
Frequently asked questions
- How do I find recruiting Dementia clinical trials?
- Browse the actively recruiting Dementia studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Dementia clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Dementia clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.